These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 26320535)

  • 21. [Drug therapy of secondary osteoporosis: glucocorticoid-induced osteoporosis].
    Soen S
    Nihon Rinsho; 2009 May; 67(5):985-90. PubMed ID: 19432121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoid-induced osteoporosis: 2013 update.
    Mazzantini M; Di Munno O
    Reumatismo; 2014 Jul; 66(2):144-52. PubMed ID: 25069496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Secondary osteoporosis. Glucocorticoid-induced osteoporosis: Threshold of bone mineral density for vertebral fracture].
    Soen S
    Clin Calcium; 2007 Mar; 17(3):399-402. PubMed ID: 17339745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
    Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
    Osteoporos Int; 2016 May; 27(5):1709-18. PubMed ID: 26694595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in treatment of glucocorticoid-induced osteoporosis.
    Hsu E; Nanes M
    Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):411-417. PubMed ID: 28857847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoid-induced osteoporosis: an update on effects and management.
    Buehring B; Viswanathan R; Binkley N; Busse W
    J Allergy Clin Immunol; 2013 Nov; 132(5):1019-30. PubMed ID: 24176682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention and treatment of glucocorticoid-induced osteoporosis.
    Doga M; Mazziotti G; Bonadonna S; Patelli I; Bilezikian JP; Canalis E; Giustina A
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):53-8. PubMed ID: 18791353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effects of glucocorticoid on bone architecture and strength].
    Soen S
    Clin Calcium; 2013 Jul; 23(7):993-9. PubMed ID: 23811587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glucocorticoid-induced osteoporosis : treatment update].
    Soen S
    Clin Calcium; 2012 Feb; 22(2):229-35. PubMed ID: 22298077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of glucocorticoid-induced osteoporosis.
    Messina OD; Vidal LF; Wilman MV; Bultink IEM; Raterman HG; Lems W
    Aging Clin Exp Res; 2021 Apr; 33(4):793-804. PubMed ID: 33751462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club.
    Devogelaer JP; Goemaere S; Boonen S; Body JJ; Kaufman JM; Reginster JY; Rozenberg S; Boutsen Y
    Osteoporos Int; 2006 Jan; 17(1):8-19. PubMed ID: 16217586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.
    Devogelaer JP; Adler RA; Recknor C; See K; Warner MR; Wong M; Krohn K
    J Rheumatol; 2010 Jan; 37(1):141-8. PubMed ID: 19918047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoporosis management among chronic glucocorticoid users: a systematic review.
    Albaum JM; Youn S; Levesque LE; Gershon AS; Cadarette SM
    J Popul Ther Clin Pharmacol; 2014; 21(3):e486-504. PubMed ID: 25527817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Glucocorticoid and Bone. Efficacy of active vitamin D on glucocorticoid-induced osteoporosis].
    Miki T; Okamoto K
    Clin Calcium; 2014 Sep; 24(9):1387-92. PubMed ID: 25177012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Osteoporosis associated with sex hormone depletion treatment].
    Takahashi S
    Clin Calcium; 2015 Sep; 25(9):1357-65. PubMed ID: 26320536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].
    Hayakawa N; Suzuki A
    Clin Calcium; 2013 Sep; 23(9):1337-44. PubMed ID: 23999371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment].
    Di Munno O; Delle Sedie A
    Reumatismo; 2006; 58(1):11-21. PubMed ID: 16639483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis.
    Tanaka Y; Soen S; Hirata S; Okada Y; Fujiwara S; Tanaka I; Kitajima Y; Kubota T; Ebina K; Takashi Y; Inoue R; Yamauchi M; Okubo N; Ueno M; Ohata Y; Ito N; Ozono K; Nakayama H; Terauchi M; Tanaka S; Fukumoto S
    J Bone Miner Metab; 2024 Mar; 42(2):143-154. PubMed ID: 38538869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.
    Buckley L; Guyatt G; Fink HA; Cannon M; Grossman J; Hansen KE; Humphrey MB; Lane NE; Magrey M; Miller M; Morrison L; Rao M; Robinson AB; Saha S; Wolver S; Bannuru RR; Vaysbrot E; Osani M; Turgunbaev M; Miller AS; McAlindon T
    Arthritis Rheumatol; 2017 Aug; 69(8):1521-1537. PubMed ID: 28585373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.